XO1

Company Profile

XO1 is a virtual biopharmaceutical company developing ichorcumab, an antibody against thrombin that delivers anticoagulation without bleeding.

Company Info

  • HQ: Cambridge, UK
Founders and CEO:
  • Trevor Baglin
  • David Grainger
  • Jim Huntington
  • Richard Mason
Index Team:
Website:
xo1.co.uk
Sector:
Healthcare
Status:
Current